CMS Reopens the 2027 Bid Cycle: What Recalculated QBP Ratings Could Mean for Medicare Advantage Plans

A rare opportunity has emerged for Medicare Advantage organizations to revisit their 2027 financial outlook.

Plans Have Days, Not Weeks, to Act

CMS has established an accelerated timeline for organizations considering bid resubmission:

🔹 Notify CMS of intent to resubmit: June 22, 2026

🔹 Resubmit bids: June 29, 2026

🔹 Actuarial certification due: July 1, 2026

Organizations that receive a higher recalculated QBP rating should quickly evaluate the financial impact and operational feasibility of resubmission.

CMS stated that contracts will be held harmless if the recalculated rating is lower. In effect, impacted plans may benefit from the higher of their original or recalculated QBP rating.

For Medicare Advantage organizations, this creates a potentially significant financial opportunity—and a very short window to evaluate it.

Why This Matters

Quality Bonus Payment ratings directly impact Medicare Advantage economics through benchmark and rebate calculations. Even modest rating improvements can translate into meaningful financial implications, affecting:

• Rebate revenue

• Benefit funding

• Product competitiveness

• Bid strategy

• Margins

For plans receiving higher recalculated ratings that fall between 3.5 – 4.5 stars, the ability to resubmit bids could unlock opportunities that were not available during the original submission process.

The Financial Questions Plans Should Be Asking

While the headlines focus on ratings, the real issue is value.

Organizations should quickly assess:

What is the revenue impact?

A higher QBP rating may increase available rebate dollars, potentially creating additional funding for benefits and member programs.

Should benefit strategies be revisited?

Additional rebate revenue may support enhancements to supplemental benefits, cost-sharing structures, or competitive positioning in key markets.

Does bid resubmission create measurable value?

Not every rating increase will justify the operational effort required for bid resubmission. Organizations should quantify the financial upside before moving forward.

What are the downstream implications?

Changes to bids may affect actuarial assumptions, product design, formularies, operational readiness, and implementation planning.

Speed Matters

CMS has established compressed timelines for organizations choosing to pursue bid resubmission.

Plans that receive higher recalculated ratings will need to rapidly evaluate:

• Revenue impact

• Bid strategy

• Product implications

• Operational feasibility

• Regulatory requirements

Organizations that delay analysis risk losing valuable time needed to make informed decisions.

---

How Rebellis Can Help

Rebellis is helping Medicare Advantage organizations evaluate the financial and actuarial implications of CMS's QBP recalculation announcement.

Our team can support:

✓ QBP impact assessments

✓ Rebate and revenue modeling

✓ Bid resubmission financial analysis

✓ Scenario planning and forecasting

✓ Executive decision support

✓ Cross-functional strategy alignment

The organizations that move fastest will be best positioned to determine whether this unexpected opportunity creates meaningful value for 2027.

Contact Rebellis

If your organization received a recalculated QBP rating and is evaluating whether bid resubmission makes financial sense, we're ready to help.

Contact Rebellis today for a rapid impact assessment and strategic evaluation of your 2027 Medicare Advantage opportunities.

The deadline may be short. The financial implications could be significant.

Contact us